Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID O15550 7403 KDM6A UTX Colon adenocarcinoma Ubiquitination N K225 O15550 7403 KDM6A UTX Kabuki syndrome Ubiquitination N K225 O15550 7403 KDM6A UTX Germ cell cancer Methylation N R519 O15550 7403 KDM6A UTX Head and neck cancer Methylation N R519 O15550 7403 KDM6A UTX Lung cancer Methylation N R519 O15550 7403 KDM6A UTX Malignant glioma Methylation N R519 O15550 7403 KDM6A UTX Urinary bladder cancer Methylation N R519 O15550 7403 KDM6A UTX Stomach cancer Methylation N R549 O15550 7403 KDM6A UTX Cervical squamous cell carcinoma and endocervical adenocarcinoma SUMOylation N K719 O15550 7403 KDM6A UTX Thyroid carcinoma Phosphorylation N S761 O15550 7403 KDM6A UTX Breast cancer Phosphorylation N S769 O15550 7403 KDM6A UTX Thyroid carcinoma Phosphorylation N S769 O15550 7403 KDM6A UTX Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N T811 O15550 7403 KDM6A UTX Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S817 O15550 7403 KDM6A UTX Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S818 O15550 7403 KDM6A UTX Chronic myelomonocytic leukemia Phosphorylation N S829 O15550 7403 KDM6A UTX Chronic myelomonocytic leukemia Phosphorylation N S926 O15550 7403 KDM6A UTX Hepatocellular carcinoma Ubiquitination N K1053 O15550 7403 KDM6A UTX Hepatocellular carcinoma Phosphorylation N S1061 O15550 7403 KDM6A UTX Breast invasive carcinoma Phosphorylation N S1091 O15550 7403 KDM6A UTX Breast invasive carcinoma Ubiquitination N K1097 O15550 7403 KDM6A UTX Lymphoid neoplasm diffuse large B-cell lymphoma Ubiquitination N K1097 O15550 7403 KDM6A UTX Stomach adenocarcinoma Ubiquitination N K1097 Q15910 2146 EZH2 KMT6 Kidney renal clear cell carcinoma Ubiquitination N K7 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Ubiquitination N K7 Q15910 2146 EZH2 KMT6 Weaver syndrome Ubiquitination N K7 Q15910 2146 EZH2 KMT6 Kidney renal clear cell carcinoma Ubiquitination N K10 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Ubiquitination N K10 Q15910 2146 EZH2 KMT6 Weaver syndrome Ubiquitination N K10 Q15910 2146 EZH2 KMT6 Lung adenocarcinoma Ubiquitination N K39 Q15910 2146 EZH2 KMT6 Stomach adenocarcinoma Ubiquitination N K39 Q15910 2146 EZH2 KMT6 Weaver syndrome Ubiquitination N K39 Q15910 2146 EZH2 KMT6 Lung adenocarcinoma Ubiquitination N K61 Q15910 2146 EZH2 KMT6 Weaver syndrome Ubiquitination N K61 Q15910 2146 EZH2 KMT6 Weaver syndrome O-linked glycosylation N S75 Q15910 2146 EZH2 KMT6 Weaver syndrome O-linked glycosylation N S76 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N S76 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N S212 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Phosphorylation N S220 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N S220 Q15910 2146 EZH2 KMT6 Bladder urothelial carcinoma Acetylation N K234 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Acetylation N K234 Q15910 2146 EZH2 KMT6 Bladder urothelial carcinoma Ubiquitination N K234 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Ubiquitination N K234 Q15910 2146 EZH2 KMT6 Non-Hodgkin's lymphoma Phosphorylation N T261 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N T261 Q15910 2146 EZH2 KMT6 Bladder urothelial carcinoma Phosphorylation N S277 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N S277 Q15910 2146 EZH2 KMT6 Colon adenocarcinoma Phosphorylation N T302 Q15910 2146 EZH2 KMT6 Colon adenocarcinoma Phosphorylation N T305 Q15910 2146 EZH2 KMT6 Colon adenocarcinoma Phosphorylation N T311 Q15910 2146 EZH2 KMT6 Uterine corpus endometrial carcinoma Phosphorylation N T311 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N T311 Q15910 2146 EZH2 KMT6 Uterine corpus endometrial carcinoma Ubiquitination N K318 Q15910 2146 EZH2 KMT6 Weaver syndrome Ubiquitination N K318 Q15910 2146 EZH2 KMT6 Lung adenocarcinoma Phosphorylation C T339 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Phosphorylation N T339 Q15910 2146 EZH2 KMT6 Uterine corpus endometrial carcinoma Phosphorylation N T339 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N T339 Q15910 2146 EZH2 KMT6 Lung adenocarcinoma Phosphorylation N T345 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Phosphorylation N T345 Q15910 2146 EZH2 KMT6 Uterine corpus endometrial carcinoma Phosphorylation N T345 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N T345 Q15910 2146 EZH2 KMT6 Lung adenocarcinoma Acetylation N K348 Q15910 2146 EZH2 KMT6 Uterine corpus endometrial carcinoma Acetylation N K348 Q15910 2146 EZH2 KMT6 Cervical adenocarcinoma Phosphorylation N S362 Q15910 2146 EZH2 KMT6 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S362 Q15910 2146 EZH2 KMT6 Head and neck squamous cell carcinoma Phosphorylation N S362 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N S362 Q15910 2146 EZH2 KMT6 Cervical adenocarcinoma Phosphorylation N S363 Q15910 2146 EZH2 KMT6 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S363 Q15910 2146 EZH2 KMT6 Head and neck squamous cell carcinoma Phosphorylation N S363 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N S363 Q15910 2146 EZH2 KMT6 Cervical adenocarcinoma Phosphorylation N S366 Q15910 2146 EZH2 KMT6 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S366 Q15910 2146 EZH2 KMT6 Lung squamous cell carcinoma Phosphorylation N T367 Q15910 2146 EZH2 KMT6 Lung squamous cell carcinoma Phosphorylation N T369 Q15910 2146 EZH2 KMT6 Lung squamous cell carcinoma Phosphorylation N S380 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N T388 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Phosphorylation N S408 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Phosphorylation N S412 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Ubiquitination N K461 Q15910 2146 EZH2 KMT6 Weaver syndrome Ubiquitination N K461 Q15910 2146 EZH2 KMT6 Weaver syndrome Ubiquitination N K472 Q15910 2146 EZH2 KMT6 Breast cancer Phosphorylation N T487 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N T487 Q15910 2146 EZH2 KMT6 Weaver syndrome Methylation N K510 Q15910 2146 EZH2 KMT6 Colon adenocarcinoma Ubiquitination N K569 Q15910 2146 EZH2 KMT6 Stomach adenocarcinoma Ubiquitination N K569 Q15910 2146 EZH2 KMT6 Weaver syndrome Ubiquitination N K597 Q15910 2146 EZH2 KMT6 Stomach adenocarcinoma Ubiquitination N K602 Q15910 2146 EZH2 KMT6 Lung adenocarcinoma Ubiquitination N K629 Q15910 2146 EZH2 KMT6 Non-Hodgkin's lymphoma Ubiquitination N K634 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Ubiquitination N K634 Q15910 2146 EZH2 KMT6 Diffuse large B-cell lymphoma Phosphorylation N Y641 Q15910 2146 EZH2 KMT6 Non-Hodgkin's lymphoma Phosphorylation N Y641 Q15910 2146 EZH2 KMT6 Skin cutaneous melanoma Phosphorylation N Y641 Q15910 2146 EZH2 KMT6 Acute myeloid leukemia Phosphorylation N S690 Q15910 2146 EZH2 KMT6 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S690 Q15910 2146 EZH2 KMT6 Chronic myelomonocytic leukemia Phosphorylation N S690 Q15910 2146 EZH2 KMT6 Hepatocellular carcinoma Phosphorylation N S690 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N S690 Q15910 2146 EZH2 KMT6 Breast invasive carcinoma Ubiquitination N K713 Q15910 2146 EZH2 KMT6 Weaver syndrome Ubiquitination N K713 Q15910 2146 EZH2 KMT6 Breast invasive carcinoma Phosphorylation N T718 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N T718 Q15910 2146 EZH2 KMT6 Weaver syndrome Phosphorylation N S729 Q15910 2146 EZH2 KMT6 Weaver syndrome Methylation N K735 Q15910 2146 EZH2 KMT6 Weaver syndrome Ubiquitination N K735 Q15910 2146 EZH2 KMT6 Weaver syndrome Ubiquitination N K735 Q6N021 54790 TET2 KIAA1546 Nbla00191 Lung squamous cell carcinoma Phosphorylation N S15 Q6N021 54790 TET2 KIAA1546 Nbla00191 Melanoma Phosphorylation N S15 Q6N021 54790 TET2 KIAA1546 Nbla00191 Skin cutaneous melanoma Phosphorylation N S15 Q6N021 54790 TET2 KIAA1546 Nbla00191 Brain lower grade glioma Phosphorylation N S21 Q6N021 54790 TET2 KIAA1546 Nbla00191 Colon adenocarcinoma Phosphorylation N S21 Q6N021 54790 TET2 KIAA1546 Nbla00191 Skin cutaneous melanoma Phosphorylation N S21 Q6N021 54790 TET2 KIAA1546 Nbla00191 Stomach adenocarcinoma Phosphorylation N S21 Q6N021 54790 TET2 KIAA1546 Nbla00191 Skin cutaneous melanoma Acetylation N K53 Q6N021 54790 TET2 KIAA1546 Nbla00191 Lung cancer Phosphorylation N S75 Q6N021 54790 TET2 KIAA1546 Nbla00191 Breast invasive carcinoma Phosphorylation N T97 Q6N021 54790 TET2 KIAA1546 Nbla00191 Breast invasive carcinoma Phosphorylation N S99 Q6N021 54790 TET2 KIAA1546 Nbla00191 Breast invasive carcinoma Phosphorylation N S102 Q6N021 54790 TET2 KIAA1546 Nbla00191 Breast invasive carcinoma Acetylation N K110 Q6N021 54790 TET2 KIAA1546 Nbla00191 Skin cutaneous melanoma Phosphorylation N S334 Q6N021 54790 TET2 KIAA1546 Nbla00191 Thyroid carcinoma Phosphorylation N S334 Q6N021 54790 TET2 KIAA1546 Nbla00191 Lung adenocarcinoma Methylation N R369 Q6N021 54790 TET2 KIAA1546 Nbla00191 Brain lower grade glioma Phosphorylation N S585 Q6N021 54790 TET2 KIAA1546 Nbla00191 Stomach adenocarcinoma Ubiquitination N K655 Q6N021 54790 TET2 KIAA1546 Nbla00191 Lung adenocarcinoma Phosphorylation N S817 Q6N021 54790 TET2 KIAA1546 Nbla00191 Chronic myelomonocytic leukemia Phosphorylation N T940 Q6N021 54790 TET2 KIAA1546 Nbla00191 Bladder urothelial carcinoma Phosphorylation N S1107 Q6N021 54790 TET2 KIAA1546 Nbla00191 Bladder urothelial carcinoma Phosphorylation N S1109 Q6N021 54790 TET2 KIAA1546 Nbla00191 Chronic myelomonocytic leukemia Ubiquitination N K1299 Q6N021 54790 TET2 KIAA1546 Nbla00191 Chronic myelomonocytic leukemia Acetylation N K1317 Q6N021 54790 TET2 KIAA1546 Nbla00191 Uterine corpus endometrial carcinoma Phosphorylation N Y1345 Q6N021 54790 TET2 KIAA1546 Nbla00191 Breast invasive carcinoma O-linked glycosylation N S1518 Q6N021 54790 TET2 KIAA1546 Nbla00191 Adrenocortical carcinoma Phosphorylation N S1559 Q6N021 54790 TET2 KIAA1546 Nbla00191 Chronic lymphocytic leukemia Phosphorylation N S1559 Q6N021 54790 TET2 KIAA1546 Nbla00191 Adrenocortical carcinoma Phosphorylation N Y1560 Q6N021 54790 TET2 KIAA1546 Nbla00191 Chronic lymphocytic leukemia Phosphorylation N Y1560 Q6N021 54790 TET2 KIAA1546 Nbla00191 Adrenocortical carcinoma Phosphorylation N S1561 Q6N021 54790 TET2 KIAA1546 Nbla00191 Chronic lymphocytic leukemia Phosphorylation N S1561 Q6N021 54790 TET2 KIAA1546 Nbla00191 secondary acute myeloid leukemia Phosphorylation N Y1902 Q6N021 54790 TET2 KIAA1546 Nbla00191 Chronic myelomonocytic leukemia Phosphorylation N Y1939 Q6N021 54790 TET2 KIAA1546 Nbla00191 Chronic myelomonocytic leukemia Phosphorylation N Y1964 Q6N021 54790 TET2 KIAA1546 Nbla00191 Chronic myelomonocytic leukemia Phosphorylation N T1975 Q9Y6K1 1788 DNMT3A Tatton-Brown-rahman syndrome Methylation N R23 Q9Y6K1 1788 DNMT3A Ovarian serous cystadenocarcinoma Phosphorylation N S75 Q9Y6K1 1788 DNMT3A Head and neck squamous cell carcinoma Phosphorylation N S105 Q9Y6K1 1788 DNMT3A Liver cancer Phosphorylation N S105 Q9Y6K1 1788 DNMT3A Colon adenocarcinoma Phosphorylation N S199 Q9Y6K1 1788 DNMT3A Hepatocellular carcinoma Phosphorylation N S199 Q9Y6K1 1788 DNMT3A Thyroid carcinoma Phosphorylation N S199 Q9Y6K1 1788 DNMT3A Thyroid carcinoma Ubiquitination N K200 Q9Y6K1 1788 DNMT3A Tatton-Brown-rahman syndrome Phosphorylation C S236 Q9Y6K1 1788 DNMT3A Skin cutaneous melanoma Phosphorylation N S236 Q9Y6K1 1788 DNMT3A Skin cutaneous melanoma Phosphorylation N S243 Q9Y6K1 1788 DNMT3A Tatton-Brown-rahman syndrome Phosphorylation N S243 Q9Y6K1 1788 DNMT3A Brain lower grade glioma Phosphorylation N S255 Q9Y6K1 1788 DNMT3A Lung adenocarcinoma Phosphorylation N S255 Q9Y6K1 1788 DNMT3A Brain lower grade glioma Phosphorylation N T261 Q9Y6K1 1788 DNMT3A Breast invasive carcinoma Phosphorylation N T261 Q9Y6K1 1788 DNMT3A Lung adenocarcinoma Phosphorylation N T261 Q9Y6K1 1788 DNMT3A Breast invasive carcinoma Phosphorylation N S267 Q9Y6K1 1788 DNMT3A Inborn genetic diseases Ubiquitination N K299 Q9Y6K1 1788 DNMT3A Tatton-Brown-rahman syndrome Ubiquitination N K299 Q9Y6K1 1788 DNMT3A Uterine corpus endometrial carcinoma Ubiquitination N K299 Q9Y6K1 1788 DNMT3A Head and neck squamous cell carcinoma Ubiquitination N K367 Q9Y6K1 1788 DNMT3A Tatton-Brown-rahman syndrome Ubiquitination N K367 Q9Y6K1 1788 DNMT3A Uterus adenocarcinoma Ubiquitination N K367 Q9Y6K1 1788 DNMT3A Breast adenocarcinoma Ubiquitination N K382 Q9Y6K1 1788 DNMT3A Hepatocellular carcinoma Ubiquitination N K382 Q9Y6K1 1788 DNMT3A Glioblastoma multiforme Phosphorylation N S393 Q9Y6K1 1788 DNMT3A Lung adenocarcinoma Ubiquitination N K420 Q9Y6K1 1788 DNMT3A Colon adenocarcinoma SUMOylation N K468 Q9Y6K1 1788 DNMT3A Tatton-Brown-rahman syndrome Phosphorylation N S638 Q9Y6K1 1788 DNMT3A Tatton-Brown-rahman syndrome Phosphorylation N T645 Q9Y6K1 1788 DNMT3A Brain lower grade glioma Ubiquitination N K721 Q9Y6K1 1788 DNMT3A Colon adenocarcinoma Ubiquitination N K721 Q9Y6K1 1788 DNMT3A Kidney renal clear cell carcinoma Ubiquitination N K721 Q9Y6K1 1788 DNMT3A Lung adenocarcinoma Ubiquitination N K721 Q9Y6K1 1788 DNMT3A Tatton-Brown-rahman syndrome Ubiquitination N K721 Q9Y6K1 1788 DNMT3A Uterine corpus endometrial carcinoma Ubiquitination N K721 Q9Y6K1 1788 DNMT3A Tatton-Brown-rahman syndrome Methylation N R771 Q9Y6K1 1788 DNMT3A Lung adenocarcinoma Ubiquitination N K783 Q9Y6K1 1788 DNMT3A Tatton-Brown-rahman syndrome Ubiquitination N K783 Q9Y6K1 1788 DNMT3A Acute myeloid leukemia Phosphorylation N S839 Q9Y6K1 1788 DNMT3A Bladder urothelial carcinoma Phosphorylation N S839 Q9Y6K1 1788 DNMT3A Kidney renal papillary cell carcinoma Phosphorylation N S839 Q9Y6K1 1788 DNMT3A Renal cell carcinoma Phosphorylation N S839 Q9Y6K1 1788 DNMT3A Tatton-Brown-rahman syndrome Phosphorylation N S839 Q9Y6K1 1788 DNMT3A Acute myeloid leukemia Ubiquitination N K844 Q9Y6K1 1788 DNMT3A Tatton-Brown-rahman syndrome Ubiquitination N K844 Q9Y6K1 1788 DNMT3A Chronic myelomonocytic leukemia Methylation N R882 Q9Y6K1 1788 DNMT3A Leukemia Methylation N R882 Q9Y6K1 1788 DNMT3A Breast invasive carcinoma Phosphorylation N S894 Q9Y6K1 1788 DNMT3A Head and neck squamous cell carcinoma Phosphorylation N S894 Q9Y6K1 1788 DNMT3A Head and neck squamous cell carcinoma Ubiquitination N K906 Q9Y6K1 1788 DNMT3A Myeloproliferative neoplasms Ubiquitination N K906 Q9Y6K1 1788 DNMT3A Ovarian cancer Ubiquitination N K906 Q9Y6K1 1788 DNMT3A Tatton-Brown-rahman syndrome Ubiquitination N K906 Q9Y6K1 1788 DNMT3A Tatton-Brown-rahman syndrome Ubiquitination N K906 Q15910 2146 EZH2 KMT6 Clear cell renal cell carcinoma ccRCC tissues Ubiquitination U 37747077 Q15910 2146 EZH2 KMT6 Glioma tumor tissue Deubiquitination P 30425057 Q15910 2146 EZH2 KMT6 Prostate cancer tumor tissue Deubiquitination P 30622230 Q15910 2146 EZH2 KMT6 Breast cancer breast cancer tissues Polyubiquitination D 32895488 Q15910 2146 EZH2 KMT6 Breast cancer breast cancer cell lines Poly(ADP-ribosyl)ation D 28925391 Q9Y6K1 1788 DNMT3A Colon cancer tumor tissue Ubiquitination D 35414793 Q15910 2146 EZH2 KMT6 Diabetic nephropathy renal tissues Glycosylation D 33609540 Q15910 2146 EZH2 KMT6 Lung cancer lung cancer cells N-myristoylation U G2 34102285 Q15910 2146 EZH2 KMT6 Prostate cancer tumor tissue Serine phosphorylation U S21 34230470 Q15910 2146 EZH2 KMT6 Cancer tumor tissue Lysine methylation U K307 31693890 Q15910 2146 EZH2 KMT6 Breast cancer breast cancer cell Threonine phosphorylation D T311 34775498 Q15910 2146 EZH2 KMT6 Breast cancer breast cancer cell Arginine methylation U R342 34775498 Q15910 2146 EZH2 KMT6 Breast cancer breast cancer tissues Threonine phosphorylation D T345 32895488 Q15910 2146 EZH2 KMT6 Psoriasis skin tissue Threonine phosphorylation U T345 32701505 Q15910 2146 EZH2 KMT6 Triple-negative breast cancer breast cancer tissues Threonine phosphorylation U T367 35992062 Q15910 2146 EZH2 KMT6 Triple-negative breast cancer tumor tissue Threonine phosphorylation P T416 31704972 Q15910 2146 EZH2 KMT6 Breast cancer breast cancer tissues Threonine phosphorylation D T487 32895488 Q15910 2146 EZH2 KMT6 Lung adenocarcinoma lung cancer tissues Threonine phosphorylation U T487 32483123 Q15910 2146 EZH2 KMT6 Prostate cancer tumor tissue Lysine methylation D K735 32619406 Q6N021 54790 TET2 KIAA1546 Nbla00191 Myelodysplastic syndrome MDS-L cells Deacetylation D K1468 30146412 Q6N021 54790 TET2 KIAA1546 Nbla00191 Myelodysplastic syndrome MDS-L cells Deacetylation D K1472 30146412 Q6N021 54790 TET2 KIAA1546 Nbla00191 Myelodysplastic syndrome MDS-L cells Deacetylation D K1473 30146412 Q6N021 54790 TET2 KIAA1546 Nbla00191 Myelodysplastic syndrome MDS-L cells Deacetylation D K1478 30146412 Q9Y6K1 1788 DNMT3A Prostate cancer PCa tissues Serine phosphorylation U S393 34051063 Q15910 2146 EZH2 KMT6 Pathological cardiac hypertrophy Ubiquitination U 32380038 Q15910 2146 EZH2 KMT6 Gallbladder cancer tumor tissue Ubiquitination A 30282996 Q15910 2146 EZH2 KMT6 Breast cancer/tumor/carcinoma Methylation D 3811872 Q15910 2146 EZH2 KMT6 Breast cancer/tumor/carcinoma Methylation D 23918806 P14602 15507 Hspb1 Hsp25 Hsp27 Chronic myelomonocytic leukemia Phosphorylation P 1903943 Q6N021 54790 TET2 KIAA1546 Nbla00191 Parkinson's disease Ubiquitination D 33935952 Q15910 2146 EZH2 KMT6 HER2-positive breast cancer Serine phosphorylation U S21 37803297 Q15910 2146 EZH2 KMT6 Melanoma Serine phosphorylation U S21 26517694 Q15910 2146 EZH2 KMT6 Cancer Lysine methylation N K27 3868555;24367637 Q15910 2146 EZH2 KMT6 Malignant disease Lysine methylation P K27 24183969 Q15910 2146 EZH2 KMT6 Breast cancer Threonine phosphorylation U T311 29351847 Q15910 2146 EZH2 KMT6 Ovarian cancer Threonine phosphorylation U T311 29351847 Q15910 2146 EZH2 KMT6 Lung cancer Acetylation U K348 25800736 Q15910 2146 EZH2 KMT6 Breast cancer/tumor/carcinoma Threonine phosphorylation P T416 26279746 Q15910 2146 EZH2 KMT6 Breast cancer Threonine phosphorylation U T487 34381492 Q15910 2146 EZH2 KMT6 HER2-positive breast cancer Threonine phosphorylation U T487 37803297 Q15910 2146 EZH2 KMT6 Triple-negative breast cancer Threonine phosphorylation U T487 37803297